Cell Source Stock Alpha and Beta Analysis

CLCS Stock  USD 0.43  0.14  24.56%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cell Source. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cell Source over a specified time horizon. Remember, high Cell Source's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cell Source's market risk premium analysis include:
Beta
(4.57)
Alpha
2.26
Risk
16.78
Sharpe Ratio
0.0994
Expected Return
1.67
Please note that although Cell Source alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Cell Source did 2.26  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Cell Source stock's relative risk over its benchmark. Cell Source has a beta of 4.57  . As returns on the market increase, returns on owning Cell Source are expected to decrease by larger amounts. On the other hand, during market turmoil, Cell Source is expected to outperform it. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Cell Source Backtesting, Cell Source Valuation, Cell Source Correlation, Cell Source Hype Analysis, Cell Source Volatility, Cell Source History and analyze Cell Source Performance.

Cell Source Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cell Source market risk premium is the additional return an investor will receive from holding Cell Source long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cell Source. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cell Source's performance over market.
α2.26   β-4.57

Cell Source expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cell Source's Buy-and-hold return. Our buy-and-hold chart shows how Cell Source performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Cell Source Market Price Analysis

Market price analysis indicators help investors to evaluate how Cell Source otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cell Source shares will generate the highest return on investment. By understating and applying Cell Source otc stock market price indicators, traders can identify Cell Source position entry and exit signals to maximize returns.

Cell Source Return and Market Media

The median price of Cell Source for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 0.4 with a coefficient of variation of 30.57. The daily time series for the period is distributed with a sample standard deviation of 0.13, arithmetic mean of 0.43, and mean deviation of 0.11. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Cell Source Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cell or other otcs. Alpha measures the amount that position in Cell Source has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cell Source in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cell Source's short interest history, or implied volatility extrapolated from Cell Source options trading.

Build Portfolio with Cell Source

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Cell OTC Stock Analysis

When running Cell Source's price analysis, check to measure Cell Source's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Source is operating at the current time. Most of Cell Source's value examination focuses on studying past and present price action to predict the probability of Cell Source's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Source's price. Additionally, you may evaluate how the addition of Cell Source to your portfolios can decrease your overall portfolio volatility.